Nicholas Pajewski, Ph.D., associate professor of biostatistics and data science at Wake Forest University School of Medicine. Credit: Wake Forest University School of Medicine
November 23, 2022
Study Highlights Importance of Long-term Management of Hypertension
November 23, 2022 — In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) …
Read More
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
November 23, 2022
Exercise Testing Detects Silent Cardiovascular Dangers Common in Pediatric Cancer Survivors
November 23, 2022 — Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular…
Read More
New research by Cedars-Sinai investigators supports evidence that social factors, such as unemployment, financial difficulties, racial discrimination and other stressors, affect an individual's health. Getty Images
November 22, 2022
Racism, Stress and Stroke Outcomes
November 22, 2022 — investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-…
Read More
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options
November 22, 2022
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population
November 22, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with…
Read More
CroĂ­Valve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.
November 22, 2022
CroĂ­Valve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System
November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation…
Read More
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
November 21, 2022
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
November 21, 2022 —  Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to…
Read More
UH Cleveland Medical Center. Image courtesy of University Hospitals
November 21, 2022
Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions
November 21, 2022 —  New research published in the Journal of the American College of Cardiology shows the use of drug-…
Read More
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
November 21, 2022
High adopters of AI-enabled screening tool are more likely to diagnose left ventricular dysfunction than low adopters, Mayo Clinic study finds
November 21, 2022 —  Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled…
Read More
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
November 21, 2022
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to…
Read More
Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.
November 21, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide,…
Read More
Justin Balko, PharmD, PhD, Ingram Associate Professor of Cancer Research, and a co-corresponding author of the study. Credit: Vanderbilt University Medical Center
November 21, 2022
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
November 22, 2022 — Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint…
Read More
Screen shots of Viz PE with RV/LV ratio data (left), along with the company’s ECG Viewer (right). Both are part of the comprehensive Viz Cardio Suite designed to speed and improve patient access to innovative cardiovascular treatments. Source: Viz.ai.
November 17, 2022
Viz.ai Launches AI-Powered Viz Cardio Suite
November 17, 2022 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination,  announced the…
Read More
Figure 1. Flow chart of machine learning workflow. A machine learning (ML) model for the prediction of vessel-specific ischemia was built, trained, and tuned in the NXT trial (Analysis of Coronary Blood Flow using CT Angiography: Next Steps). The model’s predictive performance was evaluated in the PACIFIC trial (Prospective Comparison of Cardiac Positron Emission Tomography [PET]/Computed Tomography [CT]‚ Single Photon Emission Computed Tomography [SPECT]/CT Perfusion Imaging and CT Coronary Angiography wit
November 17, 2022
AI Tool Predicts Reduced Blood Flow to the Heart
November 17, 2022 — Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that…
Read More
Enhanced offering gives hospitals flexibility to automate scan sequences from leading vendors into one scan protocol
November 17, 2022
HeartVista, Siemens Healthineers Sign Commercial Agreement to Bring AI-Driven Image Acquisition to Hospital MRI Scanners
November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in…
Read More
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients
November 16, 2022
Viz.ai Partners with Illuminate to Improve Quality of Care for Aortic Aneurysm Patients
November 16, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today…
Read More
Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the American College of Cardiology (ACC), a global nonprofit dedicated to transforming cardiovascular care, today announced a new collaboration to develop an immersive, VR-enabled training program for cardiovascular professionals.
November 16, 2022
Osso VR and American College of Cardiology to Develop Immersive Training for Cardiovascular Professionals
November 16, 2022 — Osso VR, now the largest and fastest-growing virtual reality (VR) company in healthcare, and the …
Read More
An AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients
November 16, 2022
AI Transforms Smartwatch ECG Signals Into a Diagnostic Tool for Heart Failure
November 16, 2022 — A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect…
Read More
Certain adults with this artery-blocking condition may see more benefits with an open bypass compared to less-invasive procedures to improve circulation.
November 15, 2022
Bypass Surgery Favorable for Initial Treatment of Chronic Limb-Threatening Ischemia
November 15, 2022 Performing open bypass surgery to restore circulation for people with a severe form of peripheral…
Read More
Edwin A. Takahashi, M.D., assistant professor of radiology in the division of interventional radiology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Copyright Mayo Clinic College of Medicine
November 15, 2022
Telehealth is a Valuable Option in Cardiovascular Care, Though Challenges Remain
November 15, 2022 — Telehealth is a proven and valuable option for people with cardiovascular disease, however, there…
Read More
UMSOM researchers display first genetically modified pig heart transplanted into living patient. Image courtesy of University of Maryland School of Medicine
November 15, 2022
Unexpected Electrical Changes Seen in First Successful Transplant of Genetically-Modified Pig Heart
November 15, 2022 — Ten months after transplanting the first genetically-modified pig heart into a human patient,…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now